Skip to main content

Quantum Reports Fiscal Third Quarter 2026 Financial Results

Quantum Corporation (Nasdaq: QMCO) ("Quantum" or the "Company"), today announced financial results for its fiscal third quarter of 2026 ended December 31, 2025.

Fiscal Third Quarter 2026 Financial Summary

  • Revenue was $74.6 million, exceeding the preliminary revenue results of $72.7 million and the original guidance range of $67 million, plus or minus $2.0 million
  • Higher than expected revenue was primarily driven by strong shipments into quarter-end, and to a lesser extent, conservative assumptions related to deferred revenue contracts
  • GAAP operating expenses were $30.1 million; non-GAAP adjusted operating expenses were $26.9 million, reflecting a year-over-year reduction of over $1 million
  • GAAP net loss was $27.8 million, or ($2.03) per share
  • Non-GAAP adjusted net loss was $4.9 million, or ($0.36) per share
  • Non-GAAP adjusted EBITDA was $2.9 million

“Third quarter revenue and non-GAAP adjusted EBITDA exceeded the high end of our forecasted range, reflecting the increasing benefits we are seeing from our revitalized sales organization and restructuring initiatives,” commented Hugues Meyrath, CEO of Quantum. “Also contributing to our solid results was the significant reduction in our operating costs and increased operational efficiencies realized over the past year. As part of our go-to-market strategy, we have been working closely with customers and strategic partners to address the growing market demand for AI-ready infrastructure leveraging Quantum’s integrated platform solutions spanning the full data lifecycle. These efforts have resulted in meaningful increases in both our pipeline and backlog over the past two quarters.

“Lastly, following our recently completed exchange of term debt for convertible notes, we have significantly improved our balance sheet and also continue to evaluate viable options for the Company’s remaining term debt toward our goal of further strengthening our balance sheet. Our demonstrated progress to-date is only the beginning of what we aim to achieve over the coming quarters as we further sharpen our execution and performance across the organization.”

Fiscal Third Quarter 2026 vs. Prior Fiscal Quarter

Revenue for the fiscal third quarter of 2026 was $74.6 million, compared to $62.7 million in the fiscal second quarter of 2026. GAAP gross profit in the fiscal third quarter of 2026 was $28.9 million, or 38.8% of revenue, compared to $23.6 million, or 37.6% of revenue, in the prior fiscal quarter. Non-GAAP gross profit in the fiscal third quarter of 2026 was $28.9 million, or 38.7% of revenue, compared to $24.2 million, or 38.6% of revenue, in the prior fiscal quarter.

Total GAAP operating expenses in the fiscal third quarter of 2026 were $30.1 million, or 40.4% of revenue, compared to $31.7 million, or 50.6% of revenue, in the fiscal second quarter of 2026. Total operating expenses on a non-GAAP basis for the fiscal third quarter of 2026 were $26.9 million, or 36.1% of revenue, compared to $24.8 million, or 39.5% of revenue, in the fiscal second quarter of 2026.

GAAP net loss in the fiscal third quarter of 2026 was $27.8 million, or ($2.03) per share, compared to a GAAP net loss of $46.5 million, or ($3.49) per share, in the prior fiscal quarter. Excluding stock compensation, a non-cash loss related to debt extinguishment, restructuring charges and other non-recurring costs, non-GAAP adjusted net loss in the fiscal third quarter of 2026 was $4.9 million, or ($0.36) per share, compared to a non-GAAP adjusted net loss of $7.1 million, or ($0.54) per share, in the fiscal second quarter of 2026.

Non-GAAP adjusted EBITDA in the fiscal third quarter of 2026 was positive $2.9 million, compared to a positive $0.5 million in the fiscal second quarter of 2026.

For a reconciliation of GAAP to non-GAAP financial results, please see the financial reconciliation tables below.

Liquidity and Debt (as of December 31, 2025)

  • Cash, cash equivalents and restricted cash were $13.8 million, compared to $20.6 million as of December 31, 2024.
  • Total interest expense for the quarter was $5.9 million, compared to $6.8 million in the same period a year ago.
  • Outstanding term loan debt, excluding debt issuance costs, was $54.6 million, compared to $105.9 million as of December 31, 2024.
  • The new convertible note was fair valued at $75.9 million.

Business Outlook

Fiscal fourth quarter 2026 guidance is as follows:

  • Revenue of $68 million, plus or minus $2 million
  • Non-GAAP adjusted operating expenses of $27 million, plus or minus $2 million
  • Non-GAAP adjusted basic net loss per share of ($0.33), plus or minus $0.10
  • Non-GAAP adjusted EBITDA at breakeven, plus or minus $2 million

This assumes an effective annual tax rate of 3%; non-GAAP adjusted net loss per share assumes an average basic share count of approximately 15 million in the fiscal fourth quarter of 2026.

Conference Call and Webcast

Management will host an earnings and business update conference call today at 5:00 p.m. ET (2:00 p.m. PT). The live conference call will be accessible by dialing 866-424-3436 (U.S. Toll-Free) or +1-201-689-8058 (International) and entering conference ID 13758121. This conference call will be broadcast live over the Internet and can be accessed by all interested parties on the investor relations section of the Company's website at www.investors.quantum.com under the events and presentations tab.

A telephone replay of the conference call will be available approximately two hours after the conference call and will be available through February 19, 2026. To access the replay dial 1-877-660-6853 and enter the conference ID 13758121 at the prompt. International callers should dial +1-201-612-7415 and enter the same conference ID. Following the conclusion of the live call, a replay of the webcast will be available on the Company's website at www.quantum.com for at least 90 days.

About Quantum

Quantum delivers end-to-end data management solutions designed for the AI era. With over four decades of experience, our data platform has allowed customers to extract the maximum value from their unique, unstructured data. From high-performance ingest that powers AI applications and demanding data-intensive workloads, to massive, durable data lakes to fuel AI models, Quantum delivers the most comprehensive and cost-efficient solutions. Leading organizations in life sciences, government, media and entertainment, research, and industrial technology trust Quantum with their most valuable asset – their data. For more information, visit www.quantum.com.

Quantum is listed on Nasdaq (QMCO). Quantum and the Quantum logo are registered trademarks of Quantum Corporation and its affiliates in the United States and/or other countries. All other trademarks are the property of their respective owners.

Forward-Looking Information

The information provided in this press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are largely based on our current expectations and projections about future events and financial trends affecting our business. Such forward-looking statements include, in particular, statements related to future projections of our financial results, including for the fourth fiscal quarter of 2026; expectations related to the continued benefits of our revitalized sales organization and restructuring initiatives; expectations regarding our pipeline and backlog; expectations regarding market demand for AI-ready infrastructure leveraging our integrated platform solutions; the evaluation of options with respect to our remaining term debt in furtherance of our goal of further strengthening our balance sheet; and our focus, goals, opportunities and strategy.

These forward-looking statements may be identified by the use of terms and phrases such as “anticipates”, “believes”, “can”, “could”, “estimates”, “expects”, “forecasts”, “intends”, “may”, “plans”, “projects”, “targets”, “will”, and similar expressions or variations of these terms and similar phrases. Additionally, statements concerning future matters and other statements regarding matters that are not historical are forward-looking statements. Investors are cautioned that these forward-looking statements relate to future events or our future performance and are subject to business, economic, and other risks and uncertainties, both known and unknown, that may cause actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by any forward-looking statements.

These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, including without limitation, the following: risks related to the need to address the many challenges facing our business; the impact macroeconomic and inflationary conditions on our business, including potential disruptions to our supply chain, employees, operations, sales and overall market conditions; the competitive pressures we face; risks associated with executing our strategy; the timing, execution and realization of anticipated benefits from our sales organization revitalization and restructuring initiatives; the distribution of our products and the delivery of our services effectively; the development and transition of new products and services and the enhancement of existing products and services to meet customer needs and respond to emerging technological trends; the outcome of any legal proceedings, claims and disputes; the ability to meet stock exchange continued listing standards; risks related to our ability to implement and maintain effective internal control over financial reporting in the future; and other risks that are described herein, including but not limited to the items discussed in “Risk Factors” in our filings with the Securities and Exchange Commission (the “SEC”), including our Annual Report on Form 10-K filed with the SEC on August 26, 2025, and any subsequent reports filed with the SEC. We do not intend to update or alter our forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

QUANTUM CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except per share amounts, unaudited)

 

 

December 31, 2025

 

March 31, 2025

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

13,180

 

 

$

16,464

 

Restricted cash

 

661

 

 

 

139

 

Accounts receivable, net of allowance for credit losses of $2,730 and $99, respectively

 

59,429

 

 

 

52,502

 

Inventories

 

17,629

 

 

 

22,434

 

Prepaid expenses

 

3,744

 

 

 

2,738

 

Other current assets

 

8,976

 

 

 

8,529

 

Total current assets

 

103,619

 

 

 

102,806

 

Property and equipment, net

 

9,952

 

 

 

11,378

 

Goodwill

 

12,969

 

 

 

12,969

 

Intangible assets, net

 

 

 

 

281

 

Right-of-use assets

 

7,755

 

 

 

8,580

 

Other long-term assets

 

14,977

 

 

 

19,388

 

Total assets

$

149,272

 

 

$

155,402

 

Liabilities and Stockholders’ Deficit

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

29,953

 

 

$

31,463

 

Accrued compensation

 

9,669

 

 

 

9,214

 

Deferred revenue, current portion

 

74,917

 

 

 

75,076

 

Accrued restructuring

 

905

 

 

 

786

 

Term debt

 

52,758

 

 

 

96,486

 

Revolving credit facility

 

 

 

 

26,600

 

Warrant liabilities

 

16,335

 

 

 

 

Other accrued liabilities

 

18,639

 

 

 

17,982

 

Total current liabilities

 

203,176

 

 

 

257,607

 

Deferred revenue, net of current portion

 

33,409

 

 

 

38,847

 

Convertible Note

 

75,873

 

 

 

 

Operating lease liabilities

 

8,406

 

 

 

8,934

 

Other long-term liabilities

 

12,637

 

 

 

14,380

 

Total liabilities

 

333,501

 

 

 

319,768

 

Stockholders' deficit

 

 

 

Preferred stock, 20,000 shares authorized; no shares issued and outstanding

 

 

 

 

 

Common stock, $0.01 par value; 225,000 shares authorized; 14,135 and 6,962 shares issued and outstanding

 

141

 

 

 

70

 

Additional paid-in capital

 

850,512

 

 

 

779,645

 

Accumulated deficit

 

(1,033,976

)

 

 

(942,471

)

Accumulated other comprehensive loss

 

(906

)

 

 

(1,610

)

Total stockholders’ deficit

 

(184,229

)

 

 

(164,366

)

Total liabilities and stockholders’ deficit

$

149,272

 

 

$

155,402

 

QUANTUM CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(in thousands, except per share amounts, unaudited)

 

 

Three Months Ended December 31,

 

Nine Months Ended December 31,

 

2025

 

2024

 

2025

 

2024

Revenue:

 

 

 

 

 

 

 

Product

$

46,471

 

 

$

38,634

 

 

$

119,375

 

 

$

120,565

 

Service and subscription

 

26,520

 

 

 

27,724

 

 

 

77,082

 

 

 

84,640

 

Royalty

 

1,595

 

 

 

2,326

 

 

 

5,130

 

 

 

7,592

 

Total revenue

 

74,586

 

 

 

68,684

 

 

 

201,587

 

 

 

212,797

 

Cost of revenue:

 

 

 

 

 

 

 

Product

 

35,611

 

 

 

30,922

 

 

 

95,104

 

 

 

93,251

 

Service and subscription

 

10,043

 

 

 

9,874

 

 

 

31,287

 

 

 

33,954

 

Total cost of revenue

 

45,654

 

 

 

40,796

 

 

 

126,391

 

 

 

127,205

 

Gross profit

 

28,932

 

 

 

27,888

 

 

 

75,196

 

 

 

85,592

 

Operating expenses:

 

 

 

 

 

 

 

Sales and marketing

 

12,977

 

 

 

12,448

 

 

 

37,451

 

 

 

39,321

 

General and administrative

 

10,045

 

 

 

14,142

 

 

 

34,621

 

 

 

49,186

 

Research and development

 

5,573

 

 

 

7,683

 

 

 

17,926

 

 

 

24,255

 

Restructuring charges

 

1,525

 

 

 

1,342

 

 

 

7,141

 

 

 

2,916

 

Total operating expenses

 

30,120

 

 

 

35,615

 

 

 

97,139

 

 

 

115,678

 

Income (loss) from operations

 

(1,188

)

 

 

(7,727

)

 

 

(21,943

)

 

 

(30,086

)

Other income (expense), net

 

(387

)

 

 

960

 

 

 

(1,261

)

 

 

(429

)

Interest income

 

42

 

 

 

7

 

 

 

301

 

 

 

21

 

Interest expense

 

(5,933

)

 

 

(6,840

)

 

 

(18,675

)

 

 

(16,761

)

Change in fair value of warrant liabilities

 

7,560

 

 

 

(61,630

)

 

 

9,085

 

 

 

(56,414

)

Change in fair value of Convertible Note

 

1,599

 

 

 

 

 

 

1,599

 

 

 

 

Loss on debt extinguishment

 

(28,946

)

 

 

 

 

 

(59,641

)

 

 

(3,003

)

Loss before income taxes

 

(27,253

)

 

 

(75,230

)

 

 

(90,535

)

 

 

(106,672

)

Income tax provision

 

590

 

 

 

70

 

 

 

970

 

 

 

675

 

Net loss

$

(27,843

)

 

$

(75,300

)

 

$

(91,505

)

 

$

(107,347

)

 

 

 

 

 

 

 

 

Net loss per share - basic and diluted

$

(2.03

)

 

$

(15.35

)

 

$

(7.58

)

 

$

(22.22

)

Weighted average shares - basic and diluted

 

13,689

 

 

 

4,907

 

 

 

12,077

 

 

 

4,831

 

 

 

 

 

 

 

 

 

Net loss

$

(27,843

)

 

$

(75,300

)

 

$

(91,505

)

 

$

(107,347

)

Foreign currency translation adjustments, net

 

44

 

 

 

(1,077

)

 

 

704

 

 

 

(276

)

Total comprehensive loss

$

(27,799

)

 

$

(76,377

)

 

$

(90,801

)

 

$

(107,623

)

QUANTUM CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands, unaudited)

 

 

Nine Months Ended December 31,

 

2025

 

2024

Operating activities

 

 

 

Net loss

$

(91,505

)

 

$

(107,347

)

Adjustments to reconcile net loss to net cash provided by used in operating activities

 

 

 

Depreciation and amortization

 

2,656

 

 

 

4,440

 

Amortization of debt issuance costs

 

5,830

 

 

 

3,704

 

Non-cash lease expense

 

976

 

 

 

1,342

 

Loss on debt extinguishment

 

34,221

 

 

 

3,003

 

Provision for product and manufacturing inventories

 

4,579

 

 

 

1,165

 

Stock-based compensation

 

(1,174

)

 

 

2,376

 

Paid-in-kind interest

 

5,328

 

 

 

3,515

 

Warrants issued in connection with debt amendments

 

25,420

 

 

 

 

Change in fair value of warrant liabilities

 

(9,085

)

 

 

56,408

 

Change in fair value of Convertible Note

 

(1,599

)

 

 

 

Other non-cash

 

2,710

 

 

 

(281

)

Changes in assets and liabilities:

 

 

 

Accounts receivable, net

 

(7,446

)

 

 

6,337

 

Inventories

 

(580

)

 

 

5,625

 

Prepaid expenses

 

(1,006

)

 

 

9,406

 

Operating lease liabilities

 

(857

)

 

 

(813

)

Accounts payable

 

(2,290

)

 

 

(382

)

Accrued compensation

 

454

 

 

 

(6,512

)

Accrued restructuring charges

 

119

 

 

 

 

Deferred revenue

 

(5,597

)

 

 

(9,854

)

Other current assets

 

(478

)

 

 

(124

)

Other non-current assets

 

1,967

 

 

 

1,367

 

Other current liabilities

 

1,163

 

 

 

4,839

 

Other non-current liabilities

 

(1,244

)

 

 

1,441

 

Net cash used in operating activities

 

(37,438

)

 

 

(20,345

)

Investing activities

 

 

 

Purchases of property and equipment

 

(925

)

 

 

(4,324

)

Net cash used in investing activities

 

(925

)

 

 

(4,324

)

Financing activities

 

 

 

Borrowings of long-term debt, net of debt issuance costs

 

45,046

 

 

 

25,000

 

Borrowing of Convertible Note

 

54,718

 

 

 

 

Repayments of long-term debt on Assignment, net

 

(52,271

)

 

 

(14,092

)

Repayments of long term debt on Exchange, net

 

(56,979

)

 

 

 

Borrowings of credit facility

 

71,625

 

 

 

311,135

 

Repayments of credit facility

 

(98,682

)

 

 

(302,628

)

Proceeds from shares issued related to the SEPA, net

 

72,031

 

 

 

 

Proceeds from the issuance of common stock, net

 

81

 

 

 

 

Net cash provided by financing activities

 

35,569

 

 

 

19,415

 

Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

32

 

 

 

(3

)

Net change in cash, cash equivalents and restricted cash

 

(2,762

)

 

 

(5,257

)

Cash, cash equivalents and restricted cash at beginning of period

 

16,603

 

 

 

25,860

 

Cash, cash equivalents and restricted cash at end of period

$

13,841

 

 

$

20,603

 

 

 

 

 

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows:

Cash and cash equivalents

$

13,180

 

 

$

20,381

 

Restricted cash

 

661

 

 

 

222

 

Cash, cash equivalents and restricted cash at the end of period

$

13,841

 

 

$

20,603

 

Supplemental disclosure of cash flow information

 

 

 

Cash paid for interest

$

4,270

 

 

$

8,841

 

Cash paid for income taxes, net

$

556

 

 

$

1,798

 

Non-cash transactions

 

 

 

Purchases of property and equipment included in accounts payable

$

67

 

 

$

88

 

Right-of-use assets obtained in exchange for new lease liabilities

$

61

 

 

$

538

 

Paid-in-kind interest

$

5,328

 

 

$

3,515

 

Exchange of Term Loan for Convertible Note

$

77,472

 

 

$

 

NON-GAAP FINANCIAL MEASURES

To provide investors with additional information regarding our financial results, we have presented certain non-GAAP financial measures in this press release, including non-GAAP gross margin, non-GAAP gross profit, non-GAAP adjusted EBITDA, and non-GAAP adjusted net loss.

Non-GAAP gross margin is a non-GAAP financial measure defined by us as non-GAAP gross profit divided by GAAP revenue, where non-GAAP gross profit excludes stock-based compensation, restructuring charges, and non-recurring costs recorded in cost of revenue.

Non-GAAP adjusted EBITDA is a non-GAAP financial measure defined by us as net loss before interest expense, net, provision for income taxes, depreciation expense, stock-based compensation expense, restructuring charges, amortization of acquisition-related intangible assets, loss on debt extinguishment, non-recurring project costs, including restatement and debt-related matters, and fair value of warrants adjustments.

Non-GAAP adjusted net loss is a non-GAAP financial measure defined by us as net loss before restructuring charges, stock-based compensation expense, amortization of acquisition-related intangible assets, loss on debt extinguishment, non-recurring project costs, including restatement and debt-related matters, non-recurring interest expense, and fair value of warrants adjustments. We calculate non-GAAP adjusted net loss per basic and diluted share using the above-referenced definition of non-GAAP adjusted net loss.

We have provided below reconciliations of non-GAAP gross margin, non-GAAP gross profit, non-GAAP adjusted EBITDA and non-GAAP adjusted net loss to the most directly comparable U.S. GAAP financial measures. We have presented non-GAAP adjusted EBITDA because it is a key measure used by our management and the board of directors to understand and evaluate our core operating performance and trends, to prepare and approve our annual budget and to develop short and long-term operating plans. In particular, we believe that the exclusion of the amounts eliminated in calculating non-GAAP adjusted EBITDA can provide a useful measure for period-to-period comparisons of our core business performance. For example, in the quarter ended June 30, 2024, we excluded the costs associated with the restatement of financial statements for fiscal year 2022, fiscal year 2023 and associated quarters, and the first fiscal quarter of 2024. We do not believe it is indicative of our ongoing operations; accordingly, we have excluded the impact from our non-GAAP results. We believe non-GAAP adjusted net loss and non-GAAP adjusted net loss per basic and diluted share serve as appropriate measures to be used in evaluating the performance of our business and help our investors better compare our operating performance over multiple periods. Accordingly, we believe that the use of non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and our board of directors.

Our use of non-GAAP financial measures have limitations as analytical tools, and you should not consider them in isolation or as a substitute for analysis of our financial results as reported under U.S. GAAP. Some of these limitations are as follows:

  • Although depreciation and amortization expense are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and non-GAAP adjusted EBITDA does not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements.
  • Non-GAAP adjusted EBITDA does not reflect: (1) interest and tax payments that may represent a reduction in cash available to us; (2) capital expenditures, future requirements for capital expenditures or contractual commitments; (3) changes in, or cash requirements for, working capital needs; (4) the potentially dilutive impact of stock-based compensation expense; (5) potential future costs related to our long-term debt; (6) potential future restructuring expenses; (7) potential future costs related to business acquisitions; (8) gain (loss) on debt extinguishment, (9) and acquisition-related amortization of intangibles assets from business combinations, or (10) fair market adjustments related to the Company’s warrants.
  • Non-GAAP adjusted net loss does not reflect: (1) potential future restructuring activities; (2) the potentially dilutive impact of stock-based compensation expense; (3) potential future costs related to our long-term debt; (4) potential future costs related to business acquisitions; (5) gain (loss) on debt extinguishment; (6) acquisition-related amortization of intangibles assets from business combinations; or (7) fair market adjustments related to the Company’s warrants.

Other companies, including companies in our industry, may calculate non-GAAP financial measures differently, which reduces its usefulness as a comparative measure. Because of these and other limitations, you should consider non-GAAP adjusted EBITDA and non-GAAP adjusted net loss along with other U.S. GAAP-based financial performance measures, including various cash flow metrics and our U.S. GAAP financial results.

In addition, this press release includes forward-looking non-GAAP adjusted operating expenses, non-GAAP adjusted basic net loss per share, and non-GAAP adjusted EBITDA, each a non-GAAP measure used to describe our expected performance. We have not presented a reconciliation of these anticipated non-GAAP measures to our most comparable GAAP financial measures, because the reconciliation could not be prepared without unreasonable effort. The information necessary to prepare the reconciliations is not available on a forward-looking basis and cannot be accurately predicted. The unavailable information could have a significant impact on the calculation of the comparable GAAP financial measure.

The tables below reconcile the non-GAAP financial measures of non-GAAP gross margin, non-GAAP gross profit, non-GAAP adjusted EBITDA, non-GAAP adjusted net loss and diluted EPS with the most directly comparable GAAP financial measures (in thousands, unaudited).

Non-GAAP adjusted EBITDA

 

 

Three Months Ended December 31,

(in thousands)

2025

 

2024

GAAP net loss

$

(27,843

)

 

$

(75,300

)

Interest expense, net​

 

5,933

 

 

 

6,984

 

Provision for income taxes​

 

590

 

 

 

70

 

Depreciation expense​

 

1,270

 

 

 

1,737

 

Stock-based compensation expense​

 

(969

)

 

 

735

 

Restructuring charges​

 

1,668

 

 

 

1,845

 

Loss on debt extinguishment

 

28,946

 

 

 

 

Amortization of acquisition-related intangible assets​

 

 

 

 

233

 

Non-recurring project costs​

 

534

 

 

 

2,914

 

Loss on termination of a distribution arrangement

 

1,900

 

 

 

 

Fair value of warrants adjustments​

 

(7,560

)

 

 

61,630

 

Fair value of Convertible Note adjustments

 

(1,599

)

 

 

 

Adjusted EBITDA

$

2,870

 

 

$

848

 

Non-GAAP adjusted net loss and net loss per share

 

 

Three Months Ended December 31,

(in thousands)

2025

 

2024

GAAP net loss

$

(27,843

)

 

$

(75,300

)

Stock-based compensation expense​

 

(969

)

 

 

735

 

Restructuring charges​

 

1,668

 

 

 

1,845

 

Amortization of acquisition-related intangible assets​

 

 

 

 

233

 

Non-recurring project costs​

 

534

 

 

 

2,914

 

Non-recurring interest expense

 

 

 

 

116

 

Loss on debt extinguishment

 

28,946

 

 

 

0

 

Loss on termination of a distribution arrangement

 

1,900

 

 

 

0

 

Fair value of warrants adjustments​

 

(7,560

)

 

 

61,630

 

Fair value of Convertible Note adjustments

 

(1,599

)

 

 

 

Non-GAAP adjusted net loss

$

(4,923

)

 

$

(7,827

)

 

 

 

 

​​Non-GAAP adjusted net loss per share – basic and diluted

$

(0.36

)

 

$

(1.60

)

Weighted average shares – basic and diluted

 

13,689

 

 

 

4,907

 

Non-GAAP Costs of Good Sold

 

 

Three Months Ended December 31,

(in thousands)

2025

 

2024

GAAP Cost of revenue

$

45,654

 

 

$

40,796

Less: non-GAAP cost of revenue

 

 

 

Stock-based compensation expense​

 

(58

)

 

 

95

Restructuring charges​

 

 

 

 

136

Non-GAAP cost of revenue

$

45,712

 

 

$

40,565

Non-GAAP Gross Profit and Gross Margin

 

 

Three Months Ended December 31,

(in thousands)

2025

 

2024

GAAP Revenue

$

74,586

 

 

$

68,684

 

Less: Non-GAAP cost of revenue

 

45,712

 

 

 

40,565

 

Non-GAAP gross profit

$

28,874

 

 

$

28,119

 

Non-GAAP gross margin

 

38.7

%

 

 

40.9

%

Non-GAAP Operating Expenses

 

 

Three Months Ended December 31,

(in thousands)

2025

 

2024

GAAP operating expenses

$

30,120

 

 

$

35,615

Less: Non-GAAP operating expenses

 

 

 

Stock-based compensation expense​

 

(911

)

 

 

640

Restructuring charges​

 

1,668

 

 

 

1,709

Amortization of acquisition-related intangible assets​

 

 

 

 

233

Loss on termination of a distribution arrangement

 

1,900

 

 

 

Non-recurring project costs​

 

534

 

 

 

2,914

Non-GAAP operating expenses

$

26,929

 

 

$

30,119

 

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  201.15
+2.36 (1.19%)
AAPL  263.88
+8.10 (3.17%)
AMD  203.08
-4.24 (-2.05%)
BAC  52.74
+0.19 (0.36%)
GOOG  302.82
-3.20 (-1.05%)
META  639.29
-0.48 (-0.08%)
MSFT  396.86
-4.46 (-1.11%)
NVDA  184.97
+2.16 (1.18%)
ORCL  153.97
-6.17 (-3.85%)
TSLA  410.63
-6.81 (-1.63%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.